MIRA Pharmaceuticals Inc.

MIRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.55

-$0.02 (-3.78%)

At close: Oct 30, 2026, 4:00 PM ET

$0.55

$0.00 (-0.67%)

Pre-market: Nov 2, 2026, 9:25 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.78%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

21.5

+4.5 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #976/1028 (Top 95%)

Full Analysis

Key Statistics

Market Data

Market Cap $23.05M

1D Range

0.51 0.59

52W Range

0.51 1.70

Valuation (TTM)

PE -0.40

PB 2.82

EV/EBITDA -1.58

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $0.00

Cash Flow

FCF Yield -20.1%

SBC Adj. FCF Yield -41.7%

SBC Impact -107.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -30.4% | -38.7%

FCF 3Y | 5Y 10.6% | -15.0%

Returns

ROA -115.6%

ROE -107.0%

ROIC -115.2%

Financial Health

Net Cash

$8.11M

Current Ratio 200.08

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic...

Sector Healthcare

Industry Drug Manufacturers - General

Employees 2

IPO Date Aug 3, 2023

Website mirapharmaceuticals.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.